Menu
The development of our pipelines is introduced here.
SPP-005
Aminolevulinic acid hydrochloride
Photodynamic diagnosis to advanced gastric cancer with staging laparoscopy
Osaka University
(Provision to investigator-initiated trial)
Phase III
SPP-004
Combination of aminolevulinic acid hydrochloride and sodium ferrous citrate
Mitochondrial Disease
Saitama Medical University and National Center for Child Health and Development
(Provision to investigator-initiated trial)
Phase III
SPP-003
Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate
Renal function decline by cisplatin chemotherapy
Self-development
Phase II
Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate
Ischemia reperfusion injury
University of Oxford, University of Leicester, University of Birmingham & University of Cambridge
(Provision to investigator-initiated trial)
Under preparation
Combination of aminolevulinic acid hydrochloride and Sodium Ferrous Citrate
Brain tumor (interstitial photodynamic therapy)
University of Münster
(Provision to investigator-initiated trial)
Under preparation
Aminolevulinic acid hydrochloride
Cutaneous ulcer infected with methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Pseudomonas aeruginosa
TBD
Under preparation
Aminolevulinic acid hydrochloride
Reinforcement of cancer radiotherapy
TBD
Under preparation
Aminolevulinic acid hydrochloride
photodynamic diagnosis of bladder cancer
TBD
Under preparation
Adaptation level
Main developer
Phase
Sponsor initiated
Changing dosage of Alaglio for the bladder cancer PDD indication
In-house
Reinforcement of cancer radiotherapy
TBD
Adaptation level
Main developer
Phase
Investigator initiated
Ischemia reperfusion injury
University of Oxford/ University of Leicester/ University of Birmingham/ University of Cambridge
Sponsor initiated
Photodynamic diagnosis of breast cancer
In-house
Sponsor initiated
Additional indication of Gleolan for the photodynamic diagnosis
In-house
Investigator initiated
Interstitial photodynamic therapy for recurrence of malignant glioma
University Hospital Münster
Sponsor initiated
Interstitial photodynamic therapy for primary malignant glioma
In-house